Vision problems in Flexeril - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Vision problems, when it was recovered, drug effectiveness, race, and more among people who take Flexeril (cyclobenzaprine hydrochloride). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,307 Flexeril users. Check the latest studies of Flexeril.

What is Vision problems?

Vision problems is found to be associated with 123 conditions by eHealthMe. Check the latest studies of Vision problems.



On Apr, 02, 2026

18 people who have Vision problems while taking Flexeril were studied.

Could Flexeril cause Vision problems?

Severity of Vision problems *:

  • least: 27.78 %
  • moderate: 50.0 %
  • severe: 22.22 %
  • most severe: 0.0 %

When people recovered from Vision problems *:

  • while on drug: 12.5 %
  • after off the drug: 0.0 %
  • not yet: 87.5 %

Effectiveness of Flexeril *:

  • not at all: 0.0 %
  • somewhat: 41.18 %
  • moderate: 29.41 %
  • high: 23.53 %
  • very high: 5.88 %

Race of the people *:

  • African American, Non-Hispanic: 0.0 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 0.0 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 17.65 %
  • White, Non-Hispanic: 82.35 %

Time on Flexeril *:

  • < 1 month: 11.11 %
  • 1 - 6 months: 16.67 %
  • 6 - 12 months: 5.56 %
  • 1 - 2 years: 16.67 %
  • 2 - 5 years: 11.11 %
  • 5 - 10 years: 5.56 %
  • 10+ years: 33.33 %

Gender of people when taking Flexeril *:

  • female: 83.33 %
  • male: 16.67 %

Age of people when taking Flexeril *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.56 %
  • 30-39: 22.22 %
  • 40-49: 33.33 %
  • 50-59: 27.78 %
  • 60+: 11.11 %

Conditions people have *:

  1. Insomnia (sleeplessness): 4 people, 22.22%
  2. Stress And Anxiety: 3 people, 16.67%
  3. Migraine (headache): 3 people, 16.67%
  4. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 11.11%
  5. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 11.11%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.11%
  7. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 11.11%
  8. Pain: 2 people, 11.11%
  9. Neuralgia (pain in one or more nerves): 2 people, 11.11%
  10. Type 2 Diabetes: 1 person, 5.56%

Other drugs people take besides Flexeril *:

  1. Lyrica: 3 people, 16.67%
  2. Pantoprazole: 2 people, 11.11%
  3. Ambien: 2 people, 11.11%
  4. Folic Acid: 2 people, 11.11%
  5. Effexor Xr: 2 people, 11.11%
  6. Cymbalta: 2 people, 11.11%
  7. Zopiclone: 1 person, 5.56%
  8. Imitrex Statdose: 1 person, 5.56%
  9. Ketoprofen: 1 person, 5.56%
  10. Klonopin: 1 person, 5.56%

Other side effects people have besides Vision problems *:

  1. Headache (pain in head): 4 people, 22.22%
  2. Dizziness: 3 people, 16.67%
  3. Joint Pain: 3 people, 16.67%
  4. Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 3 people, 16.67%
  5. Fatigue (feeling of tiredness): 2 people, 11.11%
  6. Numbness In Hands Or Feet: 2 people, 11.11%
  7. Numbness And Tingling (unusual prickling sensations): 2 people, 11.11%
  8. Neuralgia (pain in one or more nerves): 2 people, 11.11%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  10. Chest Pain: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and have Vision problems?

Check whether Vision problems is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

How the study uses the data?

The study is based on cyclobenzaprine hydrochloride (the active ingredients of Flexeril). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: